Kereos

Provides biopharma developing nanotechnology therapeutics to target tumors

placeSaint Louis, Missouri, United States calendar_todayFounded 1999 groups2 employees language kereos.com

Registered entities

Investor mix

12 investors on record; lead investors include Triathlon Medical Ventures, Charter Life Sciences, Harris Group, Prolog Ventures.

Investor typeCountShare
Venture capital975%
Private equity18%
Other / undisclosed217%
Coming soon